Coagulation Factor Concentrates

Coagulation Factor Concentrates is a therapeutic biological product comprising purified or recombinant human clotting factors that, when administered intravenously, selectively correct specific coagulation factor deficiencies to restore hemostatic balance in patients with congenital or acquired bleeding disorders.

1.2K

Publications

56.5K

Citations

4.2K

Authors

1.2K

Institutions

Publications per year

2017–2026

119

Variants

Cfcs

Authors

4.2K

  1. PM
    Pier Mannuccio Mannucci

    University of Milan, Italy

    24 publications · 1.3K citations

    19

    h-index

  2. ES
    Elena Santagostino

    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy

    19 publications · 3.5K citations

    19

    h-index

  3. JP
    John Pasi

    University College London, United Kingdom

    16 publications · 1.6K citations

    15

    h-index

  4. KF
    Kathelijn Fischer

    University Medical Center Utrecht, Netherlands

    18 publications · 676 citations

    14

    h-index

  5. TW
    Trevor W. Barrowcliffe

    National Institute for Biological Standards and Control, United Kingdom

    15 publications · 474 citations

    14

    h-index

1–5 of 4.2K

Venues

  1. Haemophilia

    204 publications · 9.1K citations

    46

    h-index

  2. Blood

    62 publications · 4.6K citations

    40

    h-index

  3. Thrombosis and Haemostasis

    104 publications · 5.1K citations

    38

    h-index

  4. British Journal of Haematology

    BJH · 65 publications · 3.3K citations

    31

    h-index

  5. Transfusion

    50 publications · 1.9K citations

    28

    h-index

1–5